Vazyme(SH:688105) Xin Lang Cai Jing·2025-09-09 03:17Group 1 - The stock price of NuoVivian dropped by 2.04% on September 9, reaching 23.09 CNY per share, with a total market capitalization of 9.184 billion CNY [1] - The company has seen a year-to-date stock price increase of 4.86%, but a decline of 3.06% over the last five trading days and 10.26% over the last twenty days [1] - NuoVivian's main business revenue composition includes: 81.86% from biological reagents, 9.99% from diagnostic reagents, 3.15% from consumables, 2.96% from equipment, 1.85% from technical services, and 0.18% from other sources [1] Group 2 - As of June 30, the number of shareholders for NuoVivian increased by 2.37% to 8,596, while the average circulating shares per person decreased by 2.31% to 46,269 shares [2] - For the first half of 2025, NuoVivian reported a revenue of 606 million CNY, a year-on-year decrease of 6.63%, and a net profit attributable to shareholders of 3.1294 million CNY, down 80.63% year-on-year [2] Group 3 - Since its A-share listing, NuoVivian has distributed a total of 731 million CNY in dividends, with 611 million CNY distributed over the past three years [3]